by Ming Mui | Jan 24, 2025 | Healthcare, Investing News, Medical Use, Stock Market
Novo Nordisk (NVO) experienced a significant surge in pre-market trading on Friday, with its stock climbing 12% following the announcement of promising results from an early-stage clinical trial for its new obesity treatment, amycretin. The Danish pharmaceutical giant...
